BioMark Announces Private Placement Offering
Press Release – Biomark Announces Private Placement-March 9 2016 (PDF) ———————————————
BIOMARK Closes Previous Announced Private Placement Offering
Press_Release_-_Biomark_Closes_Private_Placement_announced_on_June_24_2016 (PDF)
BIOMARK Selected to Pitch at 2017 BCTECH Summit
News Release – BIOMARK Selected To Pitch At BCTech Summit 2017 (PDF)
BIOMARK Invited to Project Pitch Stage For GAPP Application
News Release – BIOMARK’s GAPP Success (PDF)
A supramolecular indicator displacement assay for acetyl amantadine
A supramolecular indicator displacement assay for acetyl amantadine, a proxy biomarker for spermidine/spermine N1-acetyltransferase (SSAT) activity Introduction Cancer is a leading cause of death worldwide.1 The number of new cancer cases is expected to increase 40% in the next 15 years in Canada due to an aging and growing population.2 Lung cancer is the most […]
BioMark Completes Data Collection And Submits Data for Analysis prior to Health Canada Submission
BioMark Announce Progress Towards Data Analysis (PDF)
BIOMARK CLOSES SECOND TRANCHE OF PRIVATE PLACEMENT OFFERING
Press_Release_-_Biomark_Closes_Second_Tranche_of_Private_Placement_Offering_-_Sep_2017 (PDF)
Stockhouse.com and BioMark Interview About Early Cancer Detection Podcast
Interview with BioMark CEO Rashid Ahmed about the importance of early cancer detection and details of how the BioMark technology works. [podcast_episode episode=”2159″ content=”title,excerpt,player”]
BioMark Engages Stockhouse.com Deal Room with Private Placement
F1-Press_Release_-_Engage_Stock_House_Deal_Room_-_June_2016 (PDF) ———————————————
BioMark Closes Second Tranche of Private Placement Offering
F-Press_Release_-_Second_Tranche_Private_Placement_-_$0_15_units_-_June_2016 (PDF) ———————————————